Fig. 11From: FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinomaCorrelation analysis between the expression of FANCD2 and tumor mutation burden (TMB) and microsatellite instability (MSI)Back to article page